Emmons, M. F., Anreddy, N., Cuevas, J., Steinberger, K., Yang, S., McLaughlin, M., . . . Hazlehurst, L. A. (2017). MTI-101 treatment inducing activation of Stim1 and TRPC1 expression is a determinant of response in multiple myeloma. Sci Rep.

Emmons, Michael F., Nagaraju Anreddy, Javier Cuevas, Kayla Steinberger, Shengyu Yang, Mark McLaughlin, Ariosto Silva, and Lori A. Hazlehurst. "MTI-101 Treatment Inducing Activation of Stim1 and TRPC1 Expression Is a Determinant of Response in Multiple Myeloma." Sci Rep 2017.

Emmons, Michael F., et al. "MTI-101 Treatment Inducing Activation of Stim1 and TRPC1 Expression Is a Determinant of Response in Multiple Myeloma." Sci Rep 2017.